Pharmacokinetics of Pediatric Lopinavir/Ritonavir Tablets in Children When Administered Twice Daily According to FDA Weight Bands

Autor: Bastiaans, De, Forcat, S, Lyall, H, Cressey, Tr, Hansudewechakul, R, Kanjanavanit, S, Noguera Julian, A, Königs, C, Inshaw, Jr, Chalermpantmetagul, S, Saïdi, Y, Compagnucci, A, Harper, Lm, Giaquinto, Carlo, Colbers, Ap, Burger, Dm, PENTA 18KONCERT Study Group

Publikováno v: Pediatric Infectious Disease Journal, 33, 301-5
Pediatric Infectious Disease Journal, 33, 3, pp. 301-5
The Pediatric Infectious Disease Journal; Vol 33

Contains fulltext : 136012.pdf (Publisher’s version ) (Closed access) BACKGROUND: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) are approved by the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c239d72a5a0ef59f99acd25bf1e36cc8
https://doi.org/10.1097/inf.0000000000000014

Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report.

Autor: van der Veer MA; Hospital Pharmacy, Clinical Pharmacology, 26066Amsterdam University Medical Center, Amsterdam, The Netherlands., Jacobs TG; Department of Pharmacy, Radboud Institute for Health Sciences, 601896Radboud University Medical Center, Nijmegen, The Netherlands., Bukkems LH; Hospital Pharmacy, Clinical Pharmacology, 26066Amsterdam University Medical Center, Amsterdam, The Netherlands., Colbers AP; Department of Pharmacy, Radboud Institute for Health Sciences, 601896Radboud University Medical Center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, 601896Radboud University Medical Center, Nijmegen, The Netherlands., Scherpbier HJ; Emma Children's Hospital, Pediatric Infectious Diseases, 332563Amsterdam University Medical Center, Amsterdam, The Netherlands., Bijleveld YA; Hospital Pharmacy, Clinical Pharmacology, 26066Amsterdam University Medical Center, Amsterdam, The Netherlands.

Publikováno v: Antiviral therapy [Antivir Ther] 2022 Aug; Vol. 27 (4), pp. 13596535221119932.

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.

Autor: Bukkems VE; Department of Pharmacy, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands., Smolders EJ; Department of Pharmacy, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands., Jourdain G; French National Research Institute for Sustainable Development (IRD), Marseille, France.; PHPT/IRD UMI 174, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Burger DM; Department of Pharmacy, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands., Colbers AP; Department of Pharmacy, Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands., Cressey TR; French National Research Institute for Sustainable Development (IRD), Marseille, France.; PHPT/IRD UMI 174, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Department of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Mar; Vol. 61 (3), pp. 388-393. Date of Electronic Publication: 2020 Sep 22.

Low raltegravir transfer into the breastmilk of a woman living with HIV.

Autor: Feiterna-Sperling C; Department of Pediatric Pneumonology, Immunology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Bukkems VE; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands., Teulen MJA; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands., Colbers AP; Department of Pharmacy, Radboud Institute for Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: AIDS (London, England) [AIDS] 2020 Oct 01; Vol. 34 (12), pp. 1863-1865.

Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.

Autor: Schalkwijk S; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Buaben AO; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Freriksen JJM; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Colbers AP; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Greupink R; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands., Russel FGM; Department of Pharmacology and Toxicology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. Frans.Russel@radboudumc.nl.

Publikováno v: Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Jun; Vol. 57 (6), pp. 705-716.